2026, Volume 72, Issue 1  |
| REVIEWS |
| 5-20 |
Buneeva O.A., Medvedev A.E.
The VPS35 protein and the role of its impairments in mitochondrial dysfunction in Parkinson’s disease
|
  |
| EXPERIMENTAL STUDIES |
| 21-27 |
Solovyeva M.A., Galebskaya L.V., Galkin M.A., Berdichevskiy G.M., Semenova E.V., Mikhel I.M., Rogozhin E.A., Vasina L.V.
The effect of the secretory phospholipases A2 from Gloydius blomhoffii and Gloydius halys venoms on hemostasis components in vitro
|
|
| 28-41 |
Krestinina O.V., Odinokova I.V., Zvyagina A.I., Sotnikov R.R., Sotnikova L.D., Baburina Yu.L.
Astaxanthin protects heart mitochondria from damage caused by chronic alcohol intoxication
|
|
| CLINICAL AND DIAGNOSTIC RESEARCH |
| 42-61 |
Bezrukova A.I., Basharova K.S., Galkina E.S., Epifanivskaya O.S., Baydakova G.V., Zakharova E.Yu., Pchelina S.N., Usenko T.S.
Simultaneous inhibition of mTOR and STING as an approach to reduce alpha-synuclein and lysosphingolipid levels in peripheral blood monocytederived macrophages and the SH-SY5Y cell line: implications for therapy of Parkinson’s disease
|
|
| 62-74 |
Oganesyan E.G., Zhuk A.S., Venchakova V.V., Dolgo-Saburova Yu.V., Zhorzh O.N., Zhang F.-M., Vasilyeva N.V., Taraskina A.E.
Microbiome associated with recurrent vulvovaginal candidiasis: key characteristics and potential therapeutic targets
|
|
| SHORT COMMUNICATIONS |
| 75-79 |
Mironova T.V., Taganovich A.D., Makarevich V.V., Kolesnikova T.S., Levandovskaya O.V., Shilovsky I.P., Khaitov M.R., Kadushkin A.G.
The effect of nortriptyline and its combination with mometasone on secretion of IL-6 and IL-8 by stimulated blood mononuclear cells in vitro
|
|